a public good project by the
Synthesis
Company
of California

© 2026

Tim Holland‐Letz | doi.page

0 works0 citations0 h-index

Tim Holland‐Letz

German Cancer Research Center(DE)Heidelberg University(DE)

Publications by Year

Research Areas

Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Cutaneous Melanoma Detection and Management, Optimal Experimental Design Methods

Most-Cited Works

→ The challenge of mapping the human connectome based on diffusion tractography(2017)1,400 cited
→ Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay(2013)1,033 cited
→ The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer(2014)971 cited
→ PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions(2012)919 cited
→ Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer(2013)919 cited
→ Fundamental properties of unperturbed haematopoiesis from stem cells in vivo(2015)747 cited

→ Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells(2015)

611 cited

→ Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task(2019)556 cited

→ Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients(2017)512 cited

→ The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions(2015)414 cited